1. Home
  2. CCS vs KYMR Comparison

CCS vs KYMR Comparison

Compare CCS & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCS
  • KYMR
  • Stock Information
  • Founded
  • CCS 2000
  • KYMR 2015
  • Country
  • CCS United States
  • KYMR United States
  • Employees
  • CCS N/A
  • KYMR N/A
  • Industry
  • CCS Homebuilding
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • CCS Consumer Discretionary
  • KYMR Health Care
  • Exchange
  • CCS Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • CCS 2.7B
  • KYMR 2.2B
  • IPO Year
  • CCS 2014
  • KYMR 2020
  • Fundamental
  • Price
  • CCS $62.92
  • KYMR $23.69
  • Analyst Decision
  • CCS Buy
  • KYMR Buy
  • Analyst Count
  • CCS 4
  • KYMR 13
  • Target Price
  • CCS $104.00
  • KYMR $56.69
  • AVG Volume (30 Days)
  • CCS 512.2K
  • KYMR 646.2K
  • Earning Date
  • CCS 04-23-2025
  • KYMR 05-01-2025
  • Dividend Yield
  • CCS 1.84%
  • KYMR N/A
  • EPS Growth
  • CCS 29.19
  • KYMR N/A
  • EPS
  • CCS 10.40
  • KYMR N/A
  • Revenue
  • CCS $4,398,288,000.00
  • KYMR $47,072,000.00
  • Revenue This Year
  • CCS $11.95
  • KYMR $23.40
  • Revenue Next Year
  • CCS $7.41
  • KYMR $10.68
  • P/E Ratio
  • CCS $6.05
  • KYMR N/A
  • Revenue Growth
  • CCS 19.12
  • KYMR N/A
  • 52 Week Low
  • CCS $62.29
  • KYMR $23.65
  • 52 Week High
  • CCS $108.42
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • CCS 31.00
  • KYMR 25.29
  • Support Level
  • CCS $65.22
  • KYMR $24.36
  • Resistance Level
  • CCS $68.25
  • KYMR $35.28
  • Average True Range (ATR)
  • CCS 2.27
  • KYMR 1.83
  • MACD
  • CCS -0.32
  • KYMR -0.76
  • Stochastic Oscillator
  • CCS 6.58
  • KYMR 0.43

About CCS Century Communities Inc.

Century Communities Inc is a construction company that focuses on the residential market. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its own sales representatives and independent real estate brokers. It also advertises directly to potential homebuyers through the Internet, newspapers, and trade publications. The company generates the majority revenue from the Mountain segment.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: